Predicting clinical parameters relating to glaucoma from central visual field patterns
WO2021067457A1
Objective evaluation of neurological movement disorders from medical imaging
WO2021050614A2
Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav
WO2020257771A1
Systems and methods for binocular vision evaluation and treatment
WO2020243478A1
Fibroblast growth factor 2 (fgf2) for treatment of human sensorineural hearing loss
WO2020223663A1
Winged grafts for tympanic membrane repair and augmentation
WO2020210839A1
METHODS AND COMPOSITIONS FOR IMPROVING THE ASSEMBLY OF ADENO-ASSOCIATED VIRUSES (AAVs)
WO2020198232A1
Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity
WO2020112883A1
Inhibition of lysine demethylase 1 (lsd1) induces differentiation of hair cells
WO2020086878A1
Slit beam adaptation
CA3111444A1
Light activated adhesive scaffold
AU2019325332A1
Compositions and methods for modulating transduction efficiency of adeno-associated viruses
WO2020023962A1
Inhibition of cystatins for the treatment of chronic rhinosinusitis
AU2019264991A1
Altering tissue tropism of adeno-associated viruses
EP3775266A1
Methods of making and using combinatorial barcoded nucleic acid libraries having defined variation
AU2019237541A1
CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated Usher syndrome
AU2019230001A1
Amelioration of autoimmune uveitis through blockade of CSF1R
EP3749406A1
Submucosal drug delivery apparatuses, systems, and methods
US2021030775A1
Treatment of hearing loss
WO2019139901A1
Nasal exosomes for non-invasive sampling of cns proteins
